Proinnate Numbing Cream

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use as a topical numbing agent prior to procedures involving the skin, such as tattooing. Prior to application, a patch test should be conducted to ensure suitability for the patient's skin and to confirm effective numbing.

Healthcare professionals should instruct patients to clean their hands and the treatment area thoroughly with mild soap and warm water, followed by drying the area completely. A thick layer of the numbing cream should be applied to the treatment area, ensuring coverage of both the tattooed area and its surroundings. The area should then be securely wrapped with plastic wrap and left undisturbed for 40 to 50 minutes to achieve optimal results; extending the duration of application may enhance the numbing effect. After the designated time, any remaining cream should be removed, and patients should wait an additional 5 minutes for the numbing sensation to reach its peak.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to apply a THiCK layer of numbing cream to the treatment area prior to the procedure. It is essential to ensure that both the tattooed area and its surrounding skin are adequately covered with the cream. This preparation step is crucial for achieving optimal comfort during the treatment.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to any of its ingredients.

Additionally, the following precautions should be observed: do not exceed the recommended daily dosage unless directed by a healthcare professional; avoid contact with the eyes; and do not use if the seal is broken or missing.

Warnings and Precautions

For external use only. This product is not intended for internal use, and caution should be exercised to prevent accidental ingestion.

Pregnant or breastfeeding individuals should consult a healthcare professional prior to use to ensure safety for both the mother and child.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance immediately or contact a Poison Control Center. This product should be kept out of reach of children to prevent unintentional harm.

Healthcare professionals should advise patients to discontinue use and seek medical attention if any allergic reactions occur. Additionally, if symptoms do not improve or if there is an increase in redness, irritation, swelling, pain, or other adverse effects, patients should promptly consult their doctor for further evaluation and guidance.

Side Effects

For external use only. Patients should discontinue use and consult a doctor if an allergic reaction occurs. Additionally, if symptoms do not improve or if redness, irritation, swelling, pain, or other symptoms develop or increase, medical advice should be sought.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Proinnate Numbing Cream (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical advice immediately or contact a Poison Control Center without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on managing overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical advice immediately or contact a Poison Control Center without delay.

Patients must be informed not to exceed the recommended daily dosage unless directed by a healthcare professional. They should also be cautioned to avoid contact with the eyes and to refrain from using the product if they are allergic to any of its ingredients or if the seal is broken or missing.

It is important for healthcare providers to instruct patients to stop using the product and consult a doctor if an allergic reaction occurs, if symptoms do not improve, or if any redness, irritation, swelling, pain, or other symptoms develop or worsen.

For patients who are pregnant or breastfeeding, healthcare providers should recommend consulting a health professional before using the product.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature, away from direct sunlight and moisture. To maintain safety, it is essential to keep the product out of reach of children. Once opened, the product must be discarded to ensure proper safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Proinnate Numbing Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)